Study Stopped
The investigators decided to halt the study early because the company delivering the microlearning platform was incorporated into another company.
Microlearning Application for Diabetes Prevention
Validation of a Microlearning Approach to a Diabetes Prevention Program
1 other identifier
interventional
12
1 country
1
Brief Summary
The purpose of this study is to test the effectiveness of a mobile application diabetes prevention program delivered with microlearning and microcoaching.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2021
CompletedFirst Posted
Study publicly available on registry
October 8, 2021
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2023
CompletedDecember 10, 2024
December 1, 2024
9 months
September 28, 2021
December 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Percent weight lost at 12 months from baseline weight
12 months
Secondary Outcomes (1)
change in hemoglobin A1c
12 months
Study Arms (2)
Mobile application program
EXPERIMENTALTraditional program
ACTIVE COMPARATORInterventions
Health U mobile application delivers daily microlearning modules and the health coach interactions within the Health U application
CDC recognized National DPP that follows a set curriculum with modules delivered over 12 months
Eligibility Criteria
You may qualify if:
- to 85 years old
- high risk for type 2 diabetes (history of gestational diabetes, A1c 5.7-6.4)
You may not qualify if:
- pregnant
- non-English speaker
- not comfortable using a mobile application
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Health Care
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra A Tsai, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
September 28, 2021
First Posted
October 8, 2021
Study Start
January 1, 2023
Primary Completion
September 28, 2023
Study Completion
September 28, 2023
Last Updated
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share